Nadav Kidron - 16 Mar 2023 Form 4 Insider Report for ORAMED PHARMACEUTICALS INC. (ORMP)

Role: President and CEO, Director
Signature: /s/ Nadav Kidron
Issuer symbol: ORMP
Transactions as of: 16 Mar 2023
Net transactions value: +$53,014
Form type: 4
Filing time: 16 Mar 2023, 17:10:07 UTC
Previous filing: 15 Mar 2023
Next filing: 20 Apr 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ORMP	Common Stock	Purchase	$53,014	+26,000	+26%	$2.04	126,000	16 Mar 2023	By wholly-owned corporation	F1
holding	ORMP	Common Stock						1,053,098	16 Mar 2023	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.02 to $2.04, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the above range.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.02 to $2.04, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the above range.